期刊文献+

大麻素受体1对肥胖大鼠胰岛素抵抗的影响 被引量:3

Effects of cannabinoid receptor 1 on insulin resistance in obese rats
下载PDF
导出
摘要 目的:探讨大麻素受体1(CB1受体)对肥胖大鼠胰岛素抵抗的影响。方法:32只雄性SD大鼠给予高脂鼠饲料喂养8周,制作肥胖大鼠模型。以给予普通鼠饲料喂养的6只大鼠作为正常组。将肥胖大鼠随机分为4组,S(模型组)、AW、W、A组,每组大鼠8只。正常组、模型组腹腔内注射等量生理盐水,W、A、AW组分别腹腔内注射CB1受体激动剂WIN55212-2、CB1受体抑制剂AM251、AM251+WIN55212-2;1次/d。2周后,测定大鼠血胰岛素、胰岛素原、C-肽水平,计算胰岛素原/C-肽、胰岛素原/胰岛素;进行高葡萄糖钳夹实验,计算相关参数,包括第1、2时相胰岛素分泌量(1PH和2PH)、胰岛素最大分泌量(MIS)及稳态葡萄糖输注率(GIR60-90)。结果:注药2周后,与正常组比较,模型组血胰岛素、胰岛素原、C-肽、胰岛素原/C-肽、胰岛素原/胰岛素及2PH、MIS水平升高,1PH及GIR60-90水平下降(P<0.05)。W组上述指标变化方向与模型组相同,但变化幅度大于模型组(P<0.05);A组上述指标变化方向与模型组相反,各指标水平与正常组比较,差异无统计学意义(P>0.05);AW组上述指标水平与模型组比较,差异无统计学意义(P>0.05)。结论:CB1受体激动可加重肥胖大鼠胰岛素抵抗,抑制CB1受体可逆转此效应。 Aim : To study the effects of eannabinoid receptor 1 ( CBI ) on insulin resistance in obese rats. Methods :32 male SD rats were given high-fat diet for 8 weeks to establish obese rat model, and then were randomly divided into model group, W group, A group and AW group, 8 in each group. 6 rats were given regular diet for 8 weeks as the normal control. Rats in W,A and AW groups were given CBI agonist(WlN55212-2), CBI antagonist(AM251), WIN55212-2 +AM251, respectively, and the normal control group and model group were given normal saline. Two weeks later, the serum fasting insulin, proinsulin and C-peptide (C-P) levels were measured, and proinsulin/C-P, proinsulin/insulin were calculated. Then hyperglycemic clamp was performed to evaluate the insulin sensitivity, the insulin secretion in Phase 1 ( 1 PH) , that in Phase 2(2PH), the maximum insulin secretion(MIS), and steady state glucose infusion rate(GIR60-90) were calculated. Results: Compared with those of the normal control group, the serum fasting insulin, proinsulin, C-P, proinsulin/C-P,proinsulin/insulin,2PH and M IS of model group were higher, and 1 PH and GIR60_90 were lower (P 〈 O. 05 ). Compared with those of the model group, the serum fasting insulin, proinsulin, C-P, proinsulin/C-P,proinsulin/insulin,2PH and MIS of W group were higher( P 〈 O. 05 ) , 1 PH and GIR60_90of W group were lower( P 〈 O. 05 ) , The levels of the indicators mentioned above in A group were similar to those of the normal control group( P 〉 0. 05 ). The levels of the indicators mentioned above in AW group were similar to those of the model group( P 〉 O. 05 ). Conclusion: Agitating CBI receptor could aggravate obese rats' insulin resistance. Restraining CBI receptor could reverse these effectiveness.
出处 《郑州大学学报(医学版)》 CAS 北大核心 2008年第4期643-645,共3页 Journal of Zhengzhou University(Medical Sciences)
基金 国家自然科学基金资助项目30650005
关键词 大麻素受体1激动剂 大麻素受体1抑制剂 胰岛素抵抗 肥胖 大鼠 cannabinoid receptor 1 agonist cannabinoid receptor 1 antagonist insulin resistance obese rat
  • 相关文献

参考文献9

  • 1Juan Pico P,Fuentes E, Bermudez-Silva FJ, et al. Cannabinoid receptors regulate Ca(2 + ) signals and insulin secretion in pancreatic beta-cell[J]. Cell Calcium, 2006,39 (2) :155.
  • 2白晓苏,张素华,丘彦,程庆丰,冯静,刘秀容,汪志红,青华,李启富.罗格列酮对多囊卵巢综合征患者胰岛素敏感性和β细胞功能之改善[J].第三军医大学学报,2006,28(18):1894-1896. 被引量:5
  • 3贾伟平 项坤三.第二部分:胰岛β细胞功能与糖稳定异常-高葡萄糖钳夹技术的建立及应用.中华内分泌代谢杂志,2003,19(4):4-3.
  • 4陈蕾,贾伟平,项坤三.葡萄糖钳夹技术在糖尿病研究中的应用[J].中华内分泌代谢杂志,2003,19(1):74-76. 被引量:44
  • 5包玉倩,贾伟平,朱敏,陆俊茜,陈蕾,项坤三.快速相胰岛素分泌功能的评价[J].中华内分泌代谢杂志,2004,20(2):129-131. 被引量:69
  • 6Bermudez-Siva FJ, Serrano A, Diaz Molina FJ, et al. Activation of cannabinuid CBI receptors induces glucose in tolerance in rats [ J ]. Eur J Pharmacol, 2006,531 ( 1/3 ) :282.
  • 7Van Gaal LF,Rissanen AM, Seheen A J, et al. Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients : 1 -year experience from the RIO-Europe study [ J ]. Lancet,2005,365(9 468) :1 389.
  • 8Poirier B, Bidouard JP, Cadrourele C, et al. The anti-obesity effect of rimonabant is associated with an improved serum lipid profile [ J ]. Diabetes Obes Metab, 2005,7 (1):65.
  • 9Osei-Hyiama D, DePetrillo M, Pacher P,et al. Endocannbinoid activation at hepatic CBI receptors stimulates fatty acid synthesis and contributes to diet-induced obesity[ J ]. J Clin Invest,2005,115(5) :1 298.

二级参考文献40

  • 1VRBIKOVA J,BENDLOVA B,HILL M,et al.Insulin sensitivity and beta-cell function in women with polycystic ovary syndrome[J].Diabetes Care,2002,25(7):1217 -1222.
  • 2TRIPATHY D,WESSMAN Y,GULLSTROM M,et al.Importanceof obtaining independent measures of insulin secretion and insulin sensitivity during the same test:results with the Botnia clamp[J].Diabetes Care,2003,26(5):1395-1401.
  • 3CAREY D G,COWING J,GALLOWAY G J,et al.Effect of rosiglitazone on insulin sensitivity and body composition in type 2 diabetic patients[J].Obes Res,2002,10(10):1008 -1015.
  • 4DUNAIF A,FINEGOOD D T.Beta-cell dysfunction independent of obesity and glucose intolerance in the polycystic ovary syndrome[J].J Clin Endocrinol Metab,1996,81(3):942 -947.
  • 5KAHN S E,PRIGEON R L,McCULLOCH D K,et al.Quantification of the relationship between insulin sensitivity and beta-cell function in human subjects.Evidence for a hyperbolic function[J].Diabetes,1993,42(11):1663 -1672.
  • 6BUCHANAN T A,XIANG A H,PETERS R K,et al.Preservation of pancreatic beta-cell function and prevention of type 2 diabetes by pharmacological treatment of insulin resistance in high-risk hispanic women[J].Diabetes,2002,51 (9):2796-2803.
  • 7方圻,王钟林,宁田海,邵耕,陈在嘉,陆宗良,李健斋,林传骧,周北凡,诸骏仁,诸永康,陶萍,陶寿淇,龚兰生,顾复生,游凯,戴玉华.血脂异常防治建议[J].中华心血管病杂志,1997,25(3):169-175. 被引量:3067
  • 8Ferrannini E.The theoretical bases of indirect calorimetry: a review,1988.
  • 9Defronzo RA;Tobin JD;Andres R.Glucose clamp technique: a method for quantifying insulin secretion and resistance,1979.
  • 10Scheen AJ;Lefebvre PJ.Assessment of insulin resistance in vivo:application to the study of type 2 diabetes[J],1992.

共引文献107

同被引文献10

引证文献3

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部